Atlas Trials

Switch to Oral Antibiotics in Gram-negative Bacteremia

Clinical trial NCT04146922 · COMPLETED

Trial details

NCT number
NCT04146922
Sponsor
Hamad Medical Corporation
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Escherichia Coli BacteremiaKlebsiella BacteraemiaEnterobacter BacteraemiaSerratia BacteraemiaCitrobacter BacteraemiaProteus Bacteraemia
Start date
2019-10-13
Primary completion
2022-08-30
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.